Reversibility of Purkinje cell pathology and ataxic behavior in a tetracycline-responsive transgenic model of spinocerebellar ataxia type 1 (SCA1)

被引:0
|
作者
Zu, T
Orr, HT
Clark, HB
机构
[1] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN USA
[2] Univ Minnesota, Sch Med, Inst Human Genet, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
181
引用
收藏
页码:555 / 555
页数:1
相关论文
共 50 条
  • [41] Clinical and radiological features of spinocerebellar ataxia type 1 (SCA1): A report of 12 patients from southern India
    Pal, P
    Kalladka, D
    Deb, S
    Desai, S
    Purushottam, M
    Mukherjee, M
    Sanjib, S
    Jayakumar, P
    Jain, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S200 - S200
  • [42] Analysis of amino-acid and nucleotide variants in the spinocerebellar ataxia type 1 (SCA1) gene in schizophrenic patients
    Pujana, MA
    Martorell, L
    Volpini, V
    Valero, J
    Labad, A
    Vilella, E
    Estivill, X
    HUMAN GENETICS, 1997, 99 (06) : 772 - 775
  • [43] Safety and tolerability of lithium carbonate in spinocerebellar ataxia type 1 (SCA1) patients: Lessons from a feasibility study
    Lopez, G. J.
    McElroy, B. A.
    Considine, E.
    Haubenberger, D.
    Hallett, M.
    MOVEMENT DISORDERS, 2010, 25 (07) : S194 - S194
  • [44] A NOVEL CAG REPEAT CONFIGURATION IN THE SCA1 GENE - IMPLICATIONS FOR THE MOLECULAR DIAGNOSTICS OF SPINOCEREBELLAR ATAXIA TYPE-1
    QUAN, F
    JANAS, J
    POPOVICH, BW
    HUMAN MOLECULAR GENETICS, 1995, 4 (12) : 2411 - 2413
  • [45] PRESYMPTOMATIC ANALYSIS OF SPINOCEREBELLAR ATAXIA TYPE-1 (SCA1) VIA THE EXPANSION OF THE SCA1 CAG-REPEAT IN A LARGE PEDIGREE DISPLAYING ANTICIPATION AND PARENTAL MALE BIAS
    MATILLA, T
    VOLPINI, V
    GENIS, D
    ROSELL, J
    CORRAL, J
    DAVALOS, A
    MOLINS, A
    ESTIVILL, X
    HUMAN MOLECULAR GENETICS, 1993, 2 (12) : 2123 - 2128
  • [46] Relationship between Purkinje cell marker proteins and ataxin-1 nuclear inclusions in spinocerebellar ataxia-1 (SCA-1) transgenic mice
    Vig, PJS
    Subramony, SH
    Qin, Z
    McDaniel, DO
    Fratkin, JD
    NEUROLOGY, 1999, 52 (06) : A347 - A347
  • [47] Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1)
    Pappada, Mariangela
    Melija, Sara
    Facchini, Martina
    Martino, Mara
    Minarini, Sofia
    Caproni, Anna
    Nordi, Chiara
    Rimessi, Paola
    Selvatici, Rita
    Marconi, Peggy
    STEM CELL RESEARCH, 2025, 83
  • [48] Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1
    Ripolone, Michela
    Lucchini, Valeria
    Ronchi, Dario
    Fagiolari, Gigliola
    Bordoni, Andreina
    Fortunato, Francesco
    Mondello, Stefania
    Bonato, Sara
    Meregalli, Mirella
    Torrente, Yvan
    Corti, Stefania
    Comi, Giacomo P.
    Moggio, Maurizio
    Sciacco, Monica
    JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (09) : 1576 - 1585
  • [49] Aminopyridines correct presymptomatic neuronal dysfunction and improve late behavioral and cellular phenotype in a mouse model of spinocerebellar ataxia type 1 (SCA1)
    Hourez, R.
    Servais, L.
    Gall, D.
    Pandolfo, M.
    Schiffmann, S. N.
    MOVEMENT DISORDERS, 2010, 25 (07) : S191 - S192
  • [50] Aminopyridines Correct Presymptomatic Neuronal Dysfunction and Improve Late Behavioral and Cellular Phenotype in a Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)
    Hourez, Raphael
    Servais, Laurent
    Gall, David
    Pandolfo, Massimo
    Schiffmann, Serge N.
    NEUROLOGY, 2010, 74 (09) : A359 - A359